Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Peters

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Clinical and Translational Radiation Oncology|July 19, 2021
Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancerThomas Willigenburg, Marieke J van Son, Sandrine M G van de Pol, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2019
MRI-Guided Ultrafocal HDR Brachytherapy for Localized Prostate Cancer: Median 4-Year Results of a feasibility studyMax Peters, Marieke J van Son, Marinus A Moerland, et al.
European Urology Focus|October 9, 2019
Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate CancerTaimur T Shah, Max Peters, Saiful Miah, et al.
Gynecologic Oncology|July 24, 2021
Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy studyBaukelien van Triest, Marnix Rasing, Jacobus van der Velden, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2026
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLCPeter S N van Rossum, Pim J J Damen, Francesco Cortiula, et al.
The Annals of Thoracic Surgery|August 3, 2020
Predicting Incomplete Resection in Non-Small Cell Lung Cancer Preoperatively: A Validated NomogramMarnix J A Rasing, Max Peters, Amy C Moreno, et al.
European Urology|January 15, 2019
Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre RegistryTaimur T Shah, Max Peters, David Eldred-Evans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2016
Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapyMax Peters, Jochem R N van der Voort van Zyp, Marinus A Moerland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2025
Gross tumor volume increase and need for adaptive radiotherapy in pediatric-type diffuse high-grade glioma of the midline structuresFasco van Ommen, Toon van Genechten, Mirjam E Willemsen-Bosman, et al.
BJU International|October 11, 2019
Likert vs PI-RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancerChristopher C Khoo, David Eldred-Evans, Max Peters, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Clinical and Translational Radiation Oncology|July 19, 2021
Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancerThomas Willigenburg, Marieke J van Son, Sandrine M G van de Pol, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2019
MRI-Guided Ultrafocal HDR Brachytherapy for Localized Prostate Cancer: Median 4-Year Results of a feasibility studyMax Peters, Marieke J van Son, Marinus A Moerland, et al.
European Urology Focus|October 9, 2019
Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate CancerTaimur T Shah, Max Peters, Saiful Miah, et al.
Gynecologic Oncology|July 24, 2021
Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy studyBaukelien van Triest, Marnix Rasing, Jacobus van der Velden, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2026
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLCPeter S N van Rossum, Pim J J Damen, Francesco Cortiula, et al.
The Annals of Thoracic Surgery|August 3, 2020
Predicting Incomplete Resection in Non-Small Cell Lung Cancer Preoperatively: A Validated NomogramMarnix J A Rasing, Max Peters, Amy C Moreno, et al.
European Urology|January 15, 2019
Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre RegistryTaimur T Shah, Max Peters, David Eldred-Evans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2016
Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapyMax Peters, Jochem R N van der Voort van Zyp, Marinus A Moerland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2025
Gross tumor volume increase and need for adaptive radiotherapy in pediatric-type diffuse high-grade glioma of the midline structuresFasco van Ommen, Toon van Genechten, Mirjam E Willemsen-Bosman, et al.
BJU International|October 11, 2019
Likert vs PI-RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancerChristopher C Khoo, David Eldred-Evans, Max Peters, et al.
Pageof 10